Apellis — Drug Prices & Medicare Spending
Apellis manufactures 2 drugs tracked by Medicare Part D with total spending of $690.0M.
2
Drugs Tracked
$690.0M
Medicare Spending
$2,653.85
Avg Cost/Claim
100%
Have Generics
Apellis Drugs — Ranked by Medicare Spending
| # | Drug | Generic Name | Cost/Claim | Generic? |
|---|---|---|---|---|
| 1 | Syfovre | Pegcetacoplan | $1,839.00 | Yes |
| 2 | Empaveli | Pegcetacoplan (PNH) | $19,500.00 | Yes |
Frequently Asked Questions
Apellis manufactures 2 drugs tracked by Medicare Part D, with total annual spending of $690.0M.
Empaveli (Pegcetacoplan (PNH)) is the most expensive at $19,500.00 per claim.
2 of 2 Apellis drugs (100%) have generic alternatives available. Generic drugs can save patients 30-80% compared to brand-name versions.